The Board of Directors has appointed Messrs. Barry D. Michaels and Michael Cress to serve as members of the Board of Directors of Zynex, Inc. The appointments are effective from January 10, 2018. Mr. Michaels, age 67, is a retired senior executive with both general and financial management experience in emerging growth companies. Mr. Michaels has also been appointed Audit Committee Chair of the Company's Audit Committee. Mr. Cress, age 60, currently serves as Chairman and Managing Partner of MD Cress Ventures.
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Companyâs devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâs products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
ZYNEX, INC. 
